Evaluation of the efficacy and predictive indicators of PD- 1 inhibitors combined with chemotherapy in advanced pancreatic cancer

Evaluation of the efficacy and predictive indicators of PD- 1 inhibitors combined with chemotherapy in advanced pancreatic cancer

Abstract Patients with advanced pancreatic ductal adenocarcinoma (PDAC) generally face a poor prognosis and limited therapeutic options. This study aims to evaluate the clinical efficacy of combining PD- 1 inhibitors with chemotherapy as a first-line treatment for advanced PDAC, and to explore the c...

Full description

Saved in:
Bibliographic Details
Main Authors: Tiantian Zhang, Yangyang Zhou, Yue Wu, Mengting Shi, Weijie Sun, Rui Wang
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Pancreatic ductal cancer
Immunotherapy
Efficacy
Safety
SOD
Online Access:https://doi.org/10.1038/s41598-025-97233-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items